A Review Of Cancer Immunotherapy Toxicity

03 Jul, 2020 ,

Lucy Boyce Kennedy et.al. conducted a study to focus on the toxicities of checkpoint inhibitors and chimeric antigen receptor T cells, including pathophysiology, diagnosis, and management. The researchers concluded that cornerstone of toxicity management is often steroids or immunosuppression, and ongoing studies are evaluating the effect of immunosuppression on antitumor efficacy.